✦ LIBER ✦

8001 Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Co-operative Oncology Group (HeCOG) study

✍ Scribed by Mountzios, G.; Dimopoulos, M.A.; Bamias, A.; Vourli, G.; Kalofonos, H.; Aravantinos, G.; Fountzilas, G.; Papadimitriou, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of Ifosfamide, Paclitaxel, a

✍ Meletios A. Dimopoulos; Christos A. Papadimitriou; Kyrillos Sarris; Gerassimos A 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A phase II trial of cisplatin and 5-fluo

✍ Geoffrey R. Weiss; Stephanie Green; Edward V. Hannigan; John G. Boutselis; Earl 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 543 KB

A phase II trial of cisplatin and 5-fluo

✍ GR Weiss; S Green; EV Hannigan; JG Boutselis; EA Surwit; DL Wallace; DS Alberts 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase III Study of Cisplatin With or Wit

✍ Moore, D. H. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 243 KB

Phase II trial of the combination of bry

✍ Farr Nezhat; Scott Wadler; Franco Muggia; John Mandeli; Gary Goldberg; Jamal Rah 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; McGuire, William P.; Patton, Thomas; Look 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 338 KB